The Cooper Companies, Inc. (COO)

NASDAQ · Health Care · Medical Instruments & Supplies
By Alex · Tickerpine
$76.73
-0.09 (-0.12%)
Price — last 10 years monthly, dividend-adjusted · hover for detail
Market Cap
P/E (TTM)
65.0
Forward P/E
15.4
EPS (TTM)
$1.18
ROE
2.85%
Profit Margin
5.57%
Revenue Growth
7.90%
Dividend Yield
Beta
0.82
52W High
$89.83
52W Low
$58.89
Analyst Target
$81.21

COO stock forecast: what analysts expect

Consensus rating
Buy
Avg. 12-month target
$81.21
Implied upside
+5.8%

Wall Street analysts covering The Cooper Companies, Inc. currently rate the stock a Buy on average, with a mean 12-month price target of $81.21 — +5.8% versus the last price of $76.73. Targets reflect analyst opinion, not a guarantee.

What would an investment in COO be worth today?
Run COO through our free historical return calculator.
Calculate COO returns →

COO historical returns

PeriodTotal returnAnnualized (CAGR)$1,000 grew to
1 year +13.8% +13.9% $1,138
3 years -17.0% -6.0% $830
5 years -31.9% -7.4% $681
10 years +65.3% +5.2% $1,653
20 years +521% +9.6% $6,214
Since 1983 +834% +5.3% $9,337

Based on monthly dividend-adjusted prices. See the full breakdown on what if you had invested in COO.

COO annual returns by year

2026 YTD -6.4%
2025 -10.8%
2024 -2.8%
2023 +14.5%
2022 -21.1%
2021 +15.3%
2020 +13.1%
2019 +26.3%
2018 +16.8%
2017 +24.6%

Congress trading in COO

5 members of Congress have disclosed trading COO — 6 purchases and 3 sales worth an estimated $152,501. Most recent disclosure: Jun 5, 2026.

About The Cooper Companies, Inc.

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Company website ↗

COO Key Statistics

Previous Close$76.82P/E Ratio65.0
Market CapPEG Ratio0.72
Revenue (TTM)$4.23BROE2.85%
Gross Margin65.55%ROA2.52%
Debt / Equity33.1Employees15,000

COO in plain English

COO stock: frequently asked questions

What is The Cooper Companies, Inc.'s stock price today?

The Cooper Companies, Inc. (COO) last traded at $76.73 on the NASDAQ. Over the past 52 weeks the stock has traded between $58.89 and $89.83.

Is COO stock a buy or a sell?

Wall Street analysts' consensus rating on COO is "Buy", with an average 12-month price target of $81.21 — about +5.8% versus the current price of $76.73. Analyst targets are opinions, not guarantees; always do your own research.

How much would $1,000 invested in COO 10 years ago be worth today?

A $1,000 investment in The Cooper Companies, Inc. made 10 years ago would be worth about $1,653 today (dividends reinvested) — a total return of 65%, or 5.2% per year.

Does COO pay a dividend?

No — The Cooper Companies, Inc. does not currently pay a meaningful dividend. Returns for shareholders come from changes in the share price.

What is COO's P/E ratio?

COO trades at a trailing price-to-earnings ratio of 65.0, and 15.4 times expected forward earnings. The P/E ratio tells you how many dollars investors pay for each $1 of the company's annual profit.

Do members of Congress trade COO stock?

Yes — 5 members of Congress have disclosed trades in COO under the STOCK Act, totaling 6 purchases and 3 sales worth an estimated $152,501.

What is The Cooper Companies, Inc.'s ticker symbol?

The Cooper Companies, Inc. trades under the ticker symbol COO on the NASDAQ.

Compare COO with peers

COO vs LLYEli Lilly and Company $1,220.28 COO vs JNJJohnson & Johnson $260.86 COO vs ABBVAbbVie Inc. $248.76 COO vs UNHUnitedHealth Group Incorporated $405.59 COO vs MRKMerck & Company, Inc. $132.92

Data last refreshed from public sources. Figures may be delayed. Not investment advice.